MYC and plasma cell myeloma: Although gamabufotalin has been identified as an inhibitor of c-Myc in myeloma cell lines (57), our previous study demonstrated that treatment with gamabufotalin almost had no effect on the expression of c-Myc in U-87 cells (36).